Fabio Arcidiacono (@fabarcidiacono8) 's Twitter Profile
Fabio Arcidiacono

@fabarcidiacono8

Radiation Oncologist, S.Maria Hospital, Terni

ID: 1598343210543316992

calendar_today01-12-2022 15:50:32

1,1K Tweet

307 Followers

294 Following

Giulia Marvaso (@giuliamarvaso84) 's Twitter Profile Photo

Live from #ESTRO25: From STOMP , EXTEND to RADIOSA and 🔜 X-MET—the evidence is growing: ✅SBRT alone is good. 🌟🌟 🔥SBRT + ADT is better. Personalized MDT strategies are here to stay. Stronger together 💪🏻🙌. #PCa #SBRT #MDT #XMET

Live from #ESTRO25:
From STOMP , EXTEND to RADIOSA and 🔜 X-MET—the evidence is growing:
✅SBRT alone is good.
🌟🌟 🔥SBRT + ADT is better.
Personalized MDT strategies are here to stay.
Stronger together 💪🏻🙌.
#PCa  #SBRT #MDT #XMET
Jeff Ryckman (@jryckman3) 's Twitter Profile Photo

C. Jillian Tsai, MD, PhD Drew Moghanaki Percy Lee MD Fabio Arcidiacono Such an abbreviated treatment regimen would greatly benefit the people of West Virginia. I am convinced we have the worst transport issues of any state. I hope we run such a trial in the United States, as we’d have a robust population that may benefit. ers.usda.gov/sites/default/…

<a href="/CJTsaiMDPhD/">C. Jillian Tsai, MD, PhD</a> <a href="/DrewMoghanaki/">Drew Moghanaki</a> <a href="/PercyLeeMD/">Percy Lee MD</a> <a href="/FabArcidiacono8/">Fabio Arcidiacono</a> Such an abbreviated treatment regimen would greatly benefit the people of West Virginia. I am convinced we have the worst transport issues of any state. I hope we run such a trial in the United States, as we’d have a robust population that may benefit. 

ers.usda.gov/sites/default/…
Gustavo (@gusviani) 's Twitter Profile Photo

🚨 New Study on SBRT vs. Conventional RT for Painful Bone Metastases! 🚨OncoAlert 🎯 Study Objective Compare the effectiveness of dose-escalated SBRT (20 Gy) vs. conventional RT (8 Gy) in achieving complete pain response for painful bone metastases 🏥 Methods • Design: Phase

🚨 New Study on SBRT vs. Conventional RT for Painful Bone Metastases! 🚨<a href="/OncoAlert/">OncoAlert</a> 
🎯 Study Objective
Compare the effectiveness of dose-escalated SBRT (20 Gy) vs. conventional RT (8 Gy) in achieving complete pain response for painful bone metastases
🏥 Methods
•  Design: Phase
Gustavo (@gusviani) 's Twitter Profile Photo

🚨BREAKING: RAVENS Trial Redefines Oligometastatic Prostate Care! 🚨OncoAlert 🎯 Objective: • Assess if Ra223+ SABR) delays progression in bone omCSPC by targeting subclinical disease 🏥 Methods: • RCT w/ 64 👥 (1:1 randomization) • Eligibility: ≤3 bone metastases

🚨BREAKING: RAVENS Trial Redefines Oligometastatic Prostate Care! 🚨<a href="/OncoAlert/">OncoAlert</a> 
🎯 Objective:
•  Assess if Ra223+ SABR) delays progression in bone omCSPC by targeting subclinical disease
🏥 Methods:
•  RCT w/ 64 👥 (1:1 randomization)
•  Eligibility: ≤3 bone metastases
PDBrown (@pdbrownonc) 's Twitter Profile Photo

🚨 Randomized Trial: Significantly less symptom burden with SRS compared to HA-WBRT. SRS Standard of Care for 5-20 brain mets 🚨🚨🚨

🚨 Randomized Trial: Significantly less symptom burden with SRS compared to HA-WBRT. 
SRS Standard of Care for 5-20 brain mets 🚨🚨🚨
Dr. Nina Niu Sanford (@niusanford) 's Twitter Profile Photo

After our daughter Ceci died at 15 mo of a paraspinal tumor, we’ve been committed to supporting pediatric cancer research. We’re honored this year's Cattle Baron’s Ball will establish Ceci’s Fund through the American Cancer Society. Please share/donate💕 cattlebaronsball.com

After our daughter Ceci died at 15 mo of a paraspinal tumor, we’ve been committed to supporting pediatric cancer research.

We’re honored this year's Cattle Baron’s Ball will establish Ceci’s Fund through the American Cancer Society.

Please share/donate💕
cattlebaronsball.com
Gustavo (@gusviani) 's Twitter Profile Photo

🔥 Game-Changer in Salvage RT: PSA-Guided Hormone Therapy OncoAlert 🎯 Objective: •Determine survival benefit of adding ADT to postoperative RT based on pre-RT PSA levels 🏥 Methods: •Meta-analysis of RCTs (n = 5 trials; RT ± ADT) •Short-course ADT (4–6 mo) vs long-course

🔥 Game-Changer in Salvage RT: PSA-Guided Hormone Therapy
<a href="/OncoAlert/">OncoAlert</a> 
🎯 Objective:
•Determine survival benefit of adding ADT to postoperative RT based on pre-RT PSA levels
🏥 Methods:
•Meta-analysis of RCTs (n = 5 trials; RT ± ADT)
•Short-course ADT (4–6 mo) vs long-course